Additionally, we also report the first successful synthesis of a PBNP therapeutic modality targeting Fn14, a cytokine receptor highly upregulated in GBM compared to surrounding tissue in the tumor microenvironment [23,24,30,57,58]. This evidence concerns the gene TNFRSF12A and glioblastoma.